Statistics for A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

Total visits

views
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium 0

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
java.util.UUID:4c779db0-505f-46c5-8a75-5bbc794933e3 22
java.util.UUID:358990a4-e9c6-4d72-a575-d3842cfe29b8 10
Jackson2022Phase-AAM.pdf 6
java.util.UUID:0d888d78-e8cf-466f-92ac-84ec3b2a1953 3